Funding for this research was provided by:
Canadian Institutes of Health Research (2682)
Alberta Prion Research Institute (PTM13007)
Text and Data Mining valid from 2019-08-14
First Online: 14 August 2019
Compliance with Ethical Standards
: The authors funded the open access fee. SSP acknowledges the Canadian Institutes of Health Research Transitional Operating Grant 2682, and the Alberta Prion Research Institute, Research Team Program Grant PTM13007. NRC acknowledges the Canadian Consortium for Neurodegeneration in Aging (CCNA) and Brain Canada.
: Luke McAlary declares no conflicts of interest. Steven S. Plotkin is the Chief Physics Officer, and Neil R. Cashman is the founder and Chief Scientific Officer, of ProMIS Neurosciences.